发明名称 |
TREATMENT PREDICTION INVOLVING HMGCR PROTEIN |
摘要 |
<p>The present invention provides a method for determining whether a mammalian subject having a breast cancer is likely to benefit from an endocrine treatment, comprising the steps of: providing a sample earlier obtained from said subject; evaluating the amount of HMGCR protein present in at least part of said sample, and determining a sample value corresponding to said amount; comparing the sample value obtained in step b) with a reference value; and, if said sample value is higher than said reference value, concluding that the subject is likely to benefit from an endocrine treatment. Further, a corresponding method of treatment is provided as well as further methods uses and means which may be employed in connection with breast cancer treatment or treatment prediction.</p> |
申请公布号 |
WO2009139681(A8) |
申请公布日期 |
2013.11.21 |
申请号 |
WO2009SE00066 |
申请日期 |
2009.01.30 |
申请人 |
ATLAS ANTIBODIES AB;UHLEN, MATHIAS;PONTEN, FREDRIK;JIRSTROEM, KARIN |
发明人 |
UHLEN, MATHIAS;PONTEN, FREDRIK;JIRSTROEM, KARIN |
分类号 |
C12Q1/26;G01N33/574 |
主分类号 |
C12Q1/26 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|